/
 Skin and Joint Infections  Skin and Joint Infections

Skin and Joint Infections - PowerPoint Presentation

jane-oiler
jane-oiler . @jane-oiler
Follow
345 views
Uploaded On 2020-04-04

Skin and Joint Infections - PPT Presentation

George Smulian MD 2318 Question 1 A 22 yo M is seen in clinic for a painful spot on his right leg It appeared approximately 3 days ago Of note he is on the football team at the local university On exam he is afebrile with normal heart rate and blood pressure He has no streaking or ID: 775457

days infections pain skin days infections pain skin foot zoster mrsa vancomycin risk prior erythema agents therapy tissue joint

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document " Skin and Joint Infections" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Skin and Joint Infections

George Smulian, MD

2/3/18

Slide2

Question 1

A 22 y/o M is seen in clinic for a painful spot on his right leg. It appeared approximately 3 days ago. Of note, he is on the football team at the local university. On exam he is afebrile with normal heart rate and blood pressure. He has no streaking or lymphadenopathy. A 3 cm x 3 cm tender, fluctuant lesion is palpable over his right thigh. No erythema is noted. In addition to incision and drainage, what else needs to be done?

Oral CephalexinOral DoxycyclineOral CiprofloxacinIV VancomycinClose clinical follow up

Slide3

Skin and Soft Tissue Infections

Represent a spectrum of diseaseCellulitisPurulent SSTINecrotizing infectionsSeverity classificationsMildModerate: systemic signsSevere: failed prior tx, SIRS, immunocompromised

Slide4

Slide5

Skin and Soft Tissue Infections

Risk factors

Damaged skin and diminished local host defenses

Obesity

Prior trauma

Prior cellulitis

Edema (venous or lymphatic)

Slide6

Non-Purulent Cellulitis

Typically streptococcal species; MRSA is an uncommon causeDouble-blind RCT of Cephalexin +/- SMX/TMP: no difference1Don’t biopsy or culture unless super sick or unusual circumstances (immunocompromised, animal bite, immersion)5 days of therapy is as good as 10 days if improving!2Antibiotics for non-purulent cellulitis (treat Streptococcus)Oral agents: Penicillins, Cephalosporins, ClindamycinIV agents: Cefazolin, Ceftriaxone, Pip/Tazo, Clindamycin

Pallin

et al.

CID

. 2013; 56:1754-62

Hepburn et al.

Arch

Int

Med

. 2004; 164:1669-74

Slide7

Purulent SSTIs

Incision and drainage is standardUsually Staphylococcus aureus (think MRSA)For abscess <5cm, likely don’t need antibiotics1,2Administer systemic antibiotics if:Impaired host defensesSigns of systemic infectionMultiple abscessesFailure of I&DPurulent (treat MRSA)Oral agents: SMX/TMP, Doxycycline, Clindamycin, LinezolidIV agents: Vancomycin, Daptomycin, Ceftaroline

Schmitz et al.

Ann

Emerg

Med

. 2010; 56:283-7

Lee at al.

Pediatr

Infect Dis J

. 2004; 23:123-7

Slide8

Necrotizing Fasciitis

Infection of the deeper tissues, muscle fascia and subcutaneous fatProgresses along fascia due to its poor blood supply Muscles frequently spared as very vascularOverlying tissue can appear normal or red, swollen, warm, shiny and extremely tenderRapid progression with overlying skin color change, bullae formation, frank gangreneSwelling can cause compartment syndrome and myonecrosis

Slide9

Necrotizing Fasciitis

Risk factorsDiabetesPVDImmunocompromisedRecent surgeryMicrobiologyGroup A Strept (GAS)Mixed anaerobe/aerobeStaph aureus, Vibrio vulnificus, Aeromonas hydrophila

Management

Source control via surgical debridement

Broad spectrum

abx

MRSA coverage (

Vanc

,

Dapto

, Linezolid)

PLUS

Beta-lactam/beta-lactamase inhibitor (Pip/

Tazo

) or

Carbapenem

PLUS

Clindamycin

Tailor to cultures, PCN plus

Clinda

for GAS

Slide10

Question 2

A 55 y/o F with a history of psoriatic arthritis on Infliximab presents to your clinic for a dog bite to her left hand that occurred 4 hours prior. The dog is up to date on its vaccinations. She last received a tetanus vaccination 2 yrs ago. Her vital signs are normal and her physical exam is significant only for several small punctures and abrasions of the left hand with minimal surrounding erythema. She has only mild discomfort in the area. X-ray shows no fracture, foreign body or gas. What further intervention needs to be performed?

Prescribe a 3-5 day course of Amoxicillin/ClavulanateAdmission for intravenous Ampicillin/SulbactamRepeat tetanus vaccinationConsult a hand surgeon for debridement of the affected areaNo further evaluation or therapy

Slide11

Dog/Cat Bites

Pre-emptive antimicrobial therapy (3-5 days)ImmunocompromisedAsplenicAdvanced liver diseaseEdema of the affected areaModerate to severe injuryPenetrated periosteum or joint capsuleHands, face, genitaliaUpdate tetanus toxoid vaccine

Once infected, often

polymicrobial

Staph, Strep,

Pasteurella

(cats>dogs),

Capnocytophagia

, anaerobes

Humans add

Eikenella

, anaerobic GNR’s

Amoxicillin/

Clavulanate

is always right!

If PCN allergic, consider

Moxi

, Doxy, SMX/TMP plus Metro

Slide12

Diabetic Foot Infections

Frequent co-existing immune deficiency, neuropathy,

vasculopathy

Risk factors:

Persistent ulcer >1 month

Peripheral arterial disease

Prior amputation

Recurrent ulcers

Post-traumatic foot wound

CKD

Walking barefoot

Probe to bone

Slide13

Diabetic Foot Infections

Consider infected if at least 2 of the following:

Purulent discharge

Warmth

Pain/tenderness

Swelling/Induration

Erythema

Slide14

Diabetic Foot Infections

Classify severity

Mild

No deeper than skin and subcutaneous tissues

AND

Erythema <2 cm beyond ulcer

Moderate

Extends to deeper tissue

OR

Erythema >2 cm beyond ulcer

AND

Does not meet SIRS criteria

Severe

SIRS

Evidence of systemic infection

Critical ischemia

Slide15

Lipsky

et al.

CID

. 2012; 54:132-173

Slide16

Diabetic Foot Infections

Do:

Assess for arterial insufficiency

Wound care (cleansing, debridement, pressure off loading)

Image all new infections

Cover severe infections with broad spectrum antibiotics (including

PsA

and MRSA coverage)

Don’t:

Take superficial swabs

Slide17

Question 3

A 24 y/o F patient who is a known intravenous drug user is seen in the hospital for acute onset of left knee pain. She is febrile to 101ºF and tachycardic to 110. An arthrocentesis is performed. Joint fluid analysis shows 100,000 WBCs, of which 90% are neutrophils. Fluid is sent for culture. The Gram stain is shown below. In addition to surgical intervention, which of the following is the most appropriate empiric antimicrobial therapy?

Intravenous CefazolinIntravenous VancomycinIntravenous Vancomycin and CeftriaxoneIntravenous Vancomycin and CefepimeOral Doxycycline

Slide18

Infectious Arthritis

Risk factorsAge >80 yearsDiabetes mellitusRheumatoid arthritisProsthetic jointRecent joint surgery/injectionSkin infectionIntravenous drug abuseLocationKnee, then hip

Pathogenesis

Hematogenous

spread (~70%)

Bite or trauma

Inoculation during surgery

Microbiology

Staph aureus

Other GPC’s (

Strept

)

Neisseria gonorrhea

Slide19

Infectious Arthritis

Usually monoarticularJoint painSwelling (effusion)Warmth Restricted/painful movementFever/chillsIf polyarticular think…Underlying rheum diseaseEndocarditisGonococcus

Synovial fluid analysis

>50K WBC, mostly PMNs

Gram stain positive ~40%

Synovial culture

Gram stain with

GPCs: Vancomycin

GNRs: 3

rd

gen Cephalosporin

Negative: Vancomycin (add 3

rd

gen Cephalosporin if immunocompromised)

Slide20

Question 4

63 y/o M with history of diabetes presents to your clinic for evaluation of a rash. Patient states that approximately 2 days ago he began having pain in his right shoulder. 24 hrs later he noted a red bumpy rash. He has no other complaints. The rash is shown below. What is the best course of action?

Observation onlyValacyclovir for 7 days and pain control with NSAIDsValacyclovir for 7 days and a steroid dose packValacyclovir for 7 days and pain control with GabapentinHospitalization for intravenous Acyclovir

Slide21

Herpes Zoster

Reactivation of the virus that caused chickenpox75% have prodromal pain at site of subsequent eruptionPainful, unilateral erythematous papular -> vesicular eruptionTypically restricted to a dermatomal distributionNo longer infectious once crusted over (~7-10 days)

Slide22

Herpes Zoster

ComplicationsPost-herpetic neuralgia10-15%, mostly >60 years oldHerpes zoster ophthalmicusReactivation in trigeminal ganglionAcute retinal necrosisHerpes zoster oticusRamsay Hunt syndromeIpsilateral facial paralysis, ear pain, and vesicles in the auditory canal and auricle Bacterial super-infection

Slide23

Herpes Zoster

TreatmentOral antivirals (Acyclovir, Valacyclovir, Famciclovir)Symptoms <72hrs or new lesions still arisingPain management (no role for steroids in uncomplicated)May need IV agents if neurologic complicationsPrevention: Shingrix/ZostavaxGrade 1B if ≥60 (50% RRR)Grade 2B if ≥50Not Zostervax if pregnant or immunocompromised

Treatment benefits

Lessen the severity and duration of pain associated with acute neuritis

Faster healing of skin lesions

Prevent new lesions

Reduce the risk of transmission

Prevent PHN?

Slide24

Questions?